Investors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and engaged in early discussions, they said. In February, Novo Holdings, the holding company of Novo Nordisk, acquired US-based publicly-listed contract development and manufacturing organisation Catalent for $16.5 billion.
Nifty may hit 24,060 before recovery, IT breakout imminent: Geojit’s Anand James
Despite Friday’s recovery attempt, technical charts are painting a cautious picture for Nifty in the coming week. Anand James, Chief Market Strategist at Geojit Investments
June 15, 2025